Lv11
50 积分 2022-01-29 加入
Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys
2小时前
已完结
Comparison of Maximum Drug Concentration and Area Under the Time‐Concentration Curve Between Humans and Animals for Oral and Intravenous Investigational Drugs
2小时前
已完结
Dose‐dependent pharmacokinetics: Experimental observations and theoretical considerations
3小时前
已完结
Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function
2个月前
已完结
A Phase 1 study of the anti-tissue factor antibody-drug conjugate XB002 in patients with advanced solid tumors (JEWEL-101): initial results from the dose-escalation stage
2个月前
已完结
Translational PK/PD framework for antibody-drug conjugates to inform drug discovery and development
8个月前
已完结
New ADCs bring new questions in EGFR NSCLC and beyond
1年前
已完结
PI3K inhibitors are finally coming of age
1年前
已完结
Preclinical Development of Antibody–Drug Conjugates
1年前
已完结
The story of EGFR: from signaling pathways to a potent anticancer target
1年前
已完结
皖公网安备34019202002308
